Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30701924 | 1.00 | GAA (0.33) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL30784314 | 1.00 | GAA (0.33) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL9389710 | 0.77 | ALDH1A1 (0.39) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL1516900 | 0.76 | ALDH1A1 (0.37) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL4656131 | 0.76 | ALDH1A1 (0.37) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL2873888 | 0.76 | ALDH1A1 (0.37) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL3176109 | 0.73 | — | — | |
| SCHEMBL472211 | 0.71 | — | — | |
| SCHEMBL4607972 | 0.68 | ALDH1A1 (0.37) | GAAALOX15MGAMSIMGAM2 | |
| SCHEMBL17737748 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024026424-A1 | QUINAZOLINONE DERIVATIVES AS AND RELATED USES | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |